Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Pharmaceutics ; 12(12)2020 Nov 29.
Article in English | MEDLINE | ID: mdl-33260359

ABSTRACT

Respiratory syncytial virus (RSV) is associated with adverse outcomes among immunocompromised patients. Inhaled ribavirin has been shown to improve mortality rates. The Small-Particle Aerosol Generator delivery system (SPAG-2) is the only FDA-cleared device to deliver inhaled ribavirin. However, it is difficult to set up and maintain. We developed a method for delivery of this medication using the vibrating mesh nebulizer (Aerogen®). We did not observe any adverse events with this method.

2.
J Pediatr Hematol Oncol ; 38(8): 597-601, 2016 11.
Article in English | MEDLINE | ID: mdl-27467366

ABSTRACT

BACKGROUND: Children with leukemia are at risk of developing life-threatening opportunistic pulmonary infections. The role of bronchoalveolar lavage (BAL) and lung biopsy (BX) in the management of these patients is controversial. In this study, we evaluate the yield and safety of BAL and BX in children with leukemia. PROCEDURE: We reviewed the records of all children with leukemia who underwent either BAL or BX between 1997 and 2007 at the St Jude Children's Research Hospital. RESULTS: A total of 64 patients were included, of whom 35 (55%) had BX and 29 (45%) had BAL. Positive results were obtained in 69% of BAL cohort and in 46% of BX cohort. Both procedures resulted in change in antimicrobial coverage (77% in BX, 83% in BAL). Pulmonary hemorrhage occurred in 2 patients, and transient hypoxia was the most frequent complication. All resolved without negatively impacting the clinical course. CONCLUSIONS: Both BAL and BX are safe and useful in the management of children with leukemia and pulmonary disease.


Subject(s)
Anti-Infective Agents/therapeutic use , Bronchoalveolar Lavage , Leukemia/complications , Lung Diseases/diagnosis , Lung/pathology , Biopsy , Child , Disease Management , Female , Hemorrhage , Humans , Hypoxia , Lung Diseases/complications , Lung Diseases/drug therapy , Lung Diseases/etiology , Male , Retrospective Studies
3.
Jt Comm J Qual Patient Saf ; 36(1): 43-5, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20112665

ABSTRACT

In a clinic setting, the RRT, in conjunction with the ICU intensivist, succesfully treated a septic patient with fluid resuscitation and a vasoactive medication, and subsequently facilitated a quick transport to a higher level of care. St. Jude Children's Research Hospital's successful use of the RRT in the clinic setting suggests that RRTs can be used to improve patient outcomes across the spectrum of inpatient as well as outpatient hospital settings. Our experience suggests that RRTs can be beneficial in filling a gap in patient safety in outpatient clinics.


Subject(s)
Hospital Rapid Response Team/organization & administration , Outpatient Clinics, Hospital/organization & administration , Tachycardia, Supraventricular/therapy , Adolescent , Anti-Arrhythmia Agents/therapeutic use , Antineoplastic Agents/adverse effects , Antineoplastic Agents/therapeutic use , Bone Neoplasms/drug therapy , Flecainide/therapeutic use , Humans , Male , Sarcoma, Ewing/drug therapy , Tachycardia, Supraventricular/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...